Fenofibrat Heumann

Fenofibrate Micronised is a lipid-regulating medication used to manage cholesterol and triglyceride levels. It is commonly prescribed for conditions related to high blood lipids.

Fenofibrate Micronised is primarily used to lower elevated levels of triglycerides and cholesterol in the blood. It is often recommended for individuals with conditions such as hypertriglyceridemia or mixed dyslipidemia. This medication works by reducing the production of triglycerides in the liver and increasing the breakdown of fats in the bloodstream. It is important to consult a healthcare provider to determine if Fenofibrate Micronised is suitable for your specific condition.

Common effects of Fenofibrate Micronised may include gastrointestinal discomfort, such as nausea or diarrhea. Some users might experience muscle pain or weakness. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to seek medical advice.

Fenofibrate Micronised should be used with caution in individuals with liver or kidney disease. It is important to follow the prescribed dosage and not to exceed it unless directed by a healthcare provider. Regular monitoring of liver function and lipid levels may be recommended during treatment.

Fenofibrate Micronised may interact with certain medications, including blood thinners, other lipid-lowering drugs, and some antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it may increase the risk of side effects.